◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
ASKA Pharmaceutical Holdings Co.,Ltd. — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemQ4 2025Nov 07, 2025Q4 2024Nov 08, 2024Q1 2024Mar 31, 2024Q1 2023Mar 31, 2023Q1 2022Mar 31, 2022
+Operating Income 3.3B 3.1B -- -- --
Operating Margin % 101.0% 98.7% -- -- --
+Ordinary Income 3.3B 3.1B -- -- --
Revenue Growth % 7.0% -- -- -- --
Line ItemQ4 2025Nov 07, 2025Q4 2024Nov 08, 2024Q1 2024Mar 31, 2024Q1 2023Mar 31, 2023Q1 2022Mar 31, 2022
Current Assets 58.0B 56.1B -- -- --
Total Assets 103.9B 90.7B 89.2B 84.8B 78.3B
Current Liabilities 22.9B 24.0B -- -- --
Total Liabilities 32.3B 28.8B 32.3B 34.3B 36.5B
Total Equity 71.6B 61.9B 56.9B 50.5B 41.8B
Equity Ratio -- -- 0.64 0.60 0.53
No data available for this statement.
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...